those studies collectively suggest the possibility that SARS-CoV-2 may have been circulating undetected earlier than officially acknowledged, though none have definitively rewritten the pandemic's timeline due to scientific limitations and methodological concerns. Here's a bit more detail on each:
1. Italy – September 2019
-
Study: VisMederi (in partnership with the Italian National Cancer Institute)
-
Sample Date: September 3, 2019
-
Finding: SARS-CoV-2–specific antibodies (IgG and IgM) detected in blood samples from a lung cancer screening trial.
-
Peer Review: Published in Tumori Journal (2021).
-
Significance: If accurate, this would be the earliest serological evidence of SARS-CoV-2 in humans.
-
Criticism: Cross-reactivity with other coronaviruses was a major concern; attempts to replicate the results had mixed outcomes.
France Retrospective Study (Deslandes et al., 2020)
-
Published in: International Journal of Antimicrobial Agents.
-
Finding: Retrospective testing of stored respiratory samples found SARS-CoV-2 RNA in a sample from December 27, 2019.
-
Significance: This predates the first official French COVID-19 cases by nearly a month.
-
Strength: PCR-confirmed RNA detection (not just antibodies), which is more specific.
-
https://www.sciencedirect.com/science/article/pii/S187603412100321X
CDC Study (Basavaraju et al., 2021)
-
Published in: Clinical Infectious Diseases.
-
Finding: SARS-CoV-2–reactive antibodies found in blood donations collected in mid-December 2019 from California, Oregon, and Washington.
-
Method: Serological testing for IgG antibodies, with confirmation by microneutralization assays.
-
Implication: Suggests the virus may have entered the U.S. earlier than the first known U.S. case (January 2020).
Italian Study (2022)
-
Findings: Researchers detected SARS-CoV-2 RNA in a urine sample collected on September 12, 2019, from an eight-month-old child. The child also had detectable serum levels of SARS-CoV-2 IgG and IgM antibodies.
-
Significance: This suggests potential early exposure to the virus in Italy, months before the first official cases were reported.
-
Caveats: The study's conclusions are subject to scrutiny due to concerns about test specificity and potential cross-reactivity with other coronaviruses. ?News-Medical
Scientific Interpretation
-
Antibodies alone do not definitively confirm SARS-CoV-2 infection, especially without virus sequencing or RNA evidence.
-
These findings support the possibility of sporadic undetected infections before the outbreak was officially recognized in Wuhan—but not widespread community transmission.
-
